Natco Pharma Limited Letrozole Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Letrozole Export Records India — #7 Exporter, 29 Shipments, $512.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Letrozole

India Pharmaceutical Trade Intelligence

$32.1M252 Suppliers117 CountriesHS 30049049

ExportsIndia → THAILAND48.3%India → UNITED STATES12.1%

ImportsSWITZERLAND → India$30.9K BELGIUM → India$7.4K

#1 Supplier: CIPLA LIMITED

Natco Pharma Limited — Letrozole Exporter #7 | $512.8K Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Letrozole Exporter Profile

Indian Pharmaceutical Exporter · #7 for Letrozole · $512.8K export value · DGFT Verified

Natco Pharma Limited is the #7 Indian exporter of Letrozole with $512.8K in export value and 29 verified shipments. Natco Pharma Limited holds a 1.6% market share in Letrozole exports across 6 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Letrozole Export Profile: Buyers & Destinations

Natco Pharma Limited Letrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Letrozole?

Country	Value	Shipments	Share
BRAZIL	$195.8K	15	62.5%
CANADA	$51.0K	8	16.3%
UNITED STATES	$50.0K	1	16.0%
PARAGUAY	$8.7K	2	2.8%
INDONESIA	$4.8K

Who Are the Top Buyers of Letrozole from Natco Pharma Limited?

Buyer	Country	Value	Orders
NATCOFARMA DO BRASIL LTDA,	BRAZIL	$99.0K	5
NATCOFARMA DO BRASIL LTDA	BRAZIL	$57.6K	6
BRECKENRIDGE PHARMACEUTICAL INC	UNITED STATES	$50.0K	1
NATCO PHARMA (CANADA) INC	CANADA	$47.5K	7
NATCO FARMA DO BRASIL LTDA	BRAZIL	$19.9K	1
NATCOFARMA DO BRASIL LIMITEDA,	BRAZIL	$19.3K	3
EUROQUIMICA S.A	PARAGUAY	$8.7K	2
PT NATCO LOTUS FARMA	INDONESIA	$4.8K	1
NATCO PHARMA (CANADA ) INC	CANADA	$3.6K	1
NISHANT PHARMACEUTICALS(PVT)LTD	NEPAL	$2.4K	1

Natco Pharma Limited supplies Letrozole to 11 buyers globally. The largest buyer is NATCOFARMA DO BRASIL LTDA, (BRAZIL), followed by NATCOFARMA DO BRASIL LTDA (BRAZIL) and BRECKENRIDGE PHARMACEUTICAL INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Letrozole Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
LETROZOLE TABLET USP 2.5 MG - BT 30'S	$50.0K	1
LETROZOLE 2.5MG TABLETS 30'S (OTHER REFE	$22.9K	1
LETROZOLE 2.5MG TABLETS 30'S (APPENDIX 4	$19.9K	1
LETROZOLE 2 5 MG TABLETS 30 S 19116 X 30 S APPENDIX 4R RODTEP ENTRY NO 10112 OUR REF S CI NO 125030	$19.5K	1
LETROZOLE 2.5 MG TABLETS 30'S(19079 X 30S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REF(S) CI NO:124083)	$19.4K	1
LETROZOLE 2.5 MG TABLETS 30'S(19050 X 30S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REF(S) CI NO:124081)	$19.3K	1
LETROZOLE 2.5MG TABLETS 30'S (18895X30'S)(APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S)CI NO:123268)NOS	$19.3K	3
LETROZOLE 2.5 MG TABLETS 30'S(18951 X 30S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REF(S) CI NO:124082)	$19.2K	1
LETROZOLE 2.5MG TABLETS 30'S (18797X30'S)(APPENDIX 4R, RODTEP ENTRY NO:10112)(OTHER REFERENCE(S)CI NO:124013)	$18.7K	3
LETROZOLE 2.5 MG TABLETS 30'S (18809 X 30'S) (APPENDIX 4R, RODTEP ENTRY NO:10112)(OUR REF(S) CI NO:124068)	$18.2K	1

Natco Pharma Limited exports 23 distinct Letrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LETROZOLE TABLET USP 2.5 MG - BT 30'S with 1 shipments worth $50.0K.

How Does Natco Pharma Limited Compare to Nearest Letrozole Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	ZYDUS LIFESCIENCES LIMITED	$739.2K	35	7	$21.1K
6	NAPROD LIFE SCIENCES PRIVATE LIMITED	$581.6K	12	2	$48.5K
7	NATCO PHARMA LIMITED ★	$512.8K	29	6	$17.7K
8	CADILA HEALTHCARE LIMITED	$420.2K	11	7	$38.2K
9	INTAS PHARMACEUTICALS LTD	$280.6K	19	7	$14.8K

Natco Pharma Limited ranks #7 among 252 Indian Letrozole exporters. Average shipment value of $17.7K compared to the market average of $74.0K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.

Which Indian Ports Ship Letrozole Exports?

Port	Shipments	% Share
SAHAR AIR	404	19.1%
SAHAR AIR CARGO ACC (INBOM4)	393	18.6%
MUNDRA SEA (INMUN1)	109	5.2%
AHEMDABAD AIR ACC (INAMD4)	107	5.1%
MUNDRA SEA	102	4.8%
DELHI AIR CARGO ACC (INDEL4)	100	4.7%
Bombay Air	99	4.7%
HYDERABAD AIR	89	4.2%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Letrozole Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Letrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 29 individual customs records matching Natco Pharma Limited exporting Letrozole, covering 23 formulations to 6 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 117+ countries, 508+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Letrozole

Letrozole

Natco Pharma Limited — Letrozole Exporter Profile

Natco Pharma Limited — Letrozole Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Letrozole?

Who Are the Top Buyers of Letrozole from Natco Pharma Limited?

What Is India's Total Letrozole Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Letrozole Exports?

How Does Natco Pharma Limited Compare to Other Indian Letrozole Exporters?

What Letrozole Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Letrozole to Key Markets

Brazil — ANVISA

Canada — HC

United States — FDA

How Does Natco Pharma Limited Compare to Nearest Letrozole Exporters?

Which Indian Ports Ship Letrozole Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Letrozole Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Letrozole Export Data from Natco Pharma Limited

Letrozole Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source